Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 24 February 2009, doi:10.1136/bmj.b769
Cite this as: BMJ 2009;338:b769
| The first 150 words of the full text of this article appear below. |
The new definition of myocardial infarction (MI) is timely but does not address the main issue of mild troponinaemia and overdiagnosis.1 2 Slight increases in troponin are often seen in patients with multiple comorbid conditions such as diabetes and heart or kidney failure who present with dyspnoea, infections such as pneumonia, exacerbation of chronic obstructive lung disease, or atypical symptoms.3 These patients, no doubt, are at increased risk of cardiovascular mortality.4 However, these episodes do not fulfil the definition of acute myocardial infarction but are often diagnosed as "non-ST elevation MI (NSTEMI)," increasing the incidence of myocardial infarction.2
Labelling all cases of cardiac arrest as type 3 myocardial infarction undermines the importance of other treatable causes, whereas establishing a correct diagnosis is important to tailor treatment and advocate preventive strategies in family members. Similarly, dividing myocardial infarction following cardiac procedures into two types (4 and 5) doesnt make sense when it
Malvinder S Parmar, associate professor1
1 Clinical Sciences Division, Northern Ontario School of Medicine, 640 Ross Avenue East, Suite E, Timmins, ON, Canada P4N 8P2
atbeat@ntl.sympatico.ca
Read all Rapid Responses